Two-dose measles vaccination schedules

Area of Science:

• Immunology
• Public Health
• Vaccinology

Background:

• Measles remains a significant cause of infant mortality globally, particularly in developing countries.
• Current World Health Organization (WHO) guidelines do not recommend a two-dose measles immunization schedule.
• Several industrialized nations have adopted two-dose schedules, often combining measles vaccine with mumps and rubella (MMR) vaccines.

Purpose of the Study:

• To review the potential of two-dose measles immunization schedules as a strategy for enhanced measles control.
• To identify knowledge gaps and research needs regarding two-dose schedules in developing countries.

Main Methods:

• Review of existing literature and current practices regarding measles immunization schedules.
• Discussion of the need for further research, including randomized controlled trials.

Main Results:

• Industrialized countries utilize two-dose schedules, but their applicability in developing countries is not yet established.
• Insufficient data exists on the technical and epidemiological aspects of two-dose schedules in diverse settings.
• Long-term safety data from large-scale studies is required.

Conclusions:

• Further research, including randomized controlled trials, is essential to evaluate the efficacy, safety, and immunological impact of early two-dose measles vaccination schedules.
• Existing programs with two-dose schedules should assess disease incidence, cost-effectiveness, and coverage.
• Until further evidence is available, achieving high and timely coverage with a single measles vaccine dose remains the primary global immunization objective.